Insulet Enrolls First Patients in Clinical Trial for its Omnipod Artificial Pancreas System

News The Omnipod system will combine technologies into one integrated system consisting of an on-body tubeless pump, continuous glucose monitoring technology, a modified version of Insulet's handheld controller, and security system architecture. Contributed Author:  Insulet Corporation Topics:  Diabetes